UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 827

Sortiert nach

Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cells

PloS one, 2015-03, Vol.10 (3), p.e0119837-e0119837

2015

Volltextzugriff (PDF)

Delayed presentations of pediatric solid tumors at a tertiary care hospital in the Bronx due to COVID‐19

Pediatric blood & cancer, 2021-02, Vol.68 (2), p.e28615-n/a

2021

Volltextzugriff (PDF)

IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

PloS one, 2015-07, Vol.10 (7), p.e0133152-e0133152

2015

Volltextzugriff (PDF)

Treatment pathway of bone sarcoma in children, adolescents, and young adults

Cancer, 2017-06, Vol.123 (12), p.2206-2218

2017

Volltextzugriff (PDF)

Breaking down the tumor immune infiltration within pediatric sarcomas

Frontiers in endocrinology (Lausanne), 2023-06, Vol.14, p.1187289-1187289

2023

Volltextzugriff (PDF)

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition

PloS one, 2010-11, Vol.5 (11), p.e13943

2010

Volltextzugriff (PDF)

SARS‐CoV‐2 as a mimicker of pulmonary metastasis in osteosarcoma

Pediatric blood & cancer, 2022-06, Vol.69 (6), p.e29435-n/a

2022

Volltextzugriff (PDF)

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma

PloS one, 2014-08, Vol.9 (8), p.e106249

2014

Volltextzugriff (PDF)

WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia

The Journal of biological chemistry, 2011-12, Vol.286 (51), p.43634-43643

2011

Volltextzugriff (PDF)

Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA

Cancer, 2016-10, Vol.122 (19), p.3015-3023

2016

Volltextzugriff (PDF)

Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma

PLoS genetics, 2014-01, Vol.10 (1), p.e1004107

2014

Volltextzugriff (PDF)

Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?

Pediatric blood & cancer, 2024-09, Vol.71 (9), p.e31175

2024

Volltextzugriff (PDF)

Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma

PloS one, 2014-05, Vol.9 (5), p.e95843-e95843

2014

Volltextzugriff (PDF)

Outcome for children with metastatic solid tumors over the last four decades

PloS one, 2014-07, Vol.9 (7), p.e100396

2014

Volltextzugriff (PDF)

An evolutionary framework for treating pediatric sarcomas

Cancer, 2020-06, Vol.126 (11), p.2577-2587

2020

Volltextzugriff (PDF)

Pembrolizumab as maintenance therapy for malignant rhabdoid tumor

Pediatric blood & cancer, 2022-10, Vol.69 (10), p.e29660-n/a

2022

Volltextzugriff (PDF)

Respiratory Failure Due to Idiopathic Pneumonia Syndrome in a Pediatric Patient After Recipient-derived Allogeneic Chimeric Antigen Receptor T-Cell Therapy

Journal of pediatric hematology/oncology, 2023-08, Vol.45 (6), p.e775

2023

Volltextzugriff (PDF)

Consensus and controversies regarding the treatment of rhabdomyosarcoma

Pediatric blood & cancer, 2018-02, Vol.65 (2), p.n/a

2018

Volltextzugriff (PDF)

A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy

International journal of cancer, 2017-10, Vol.141 (7), p.1469-1477

2017

Volltextzugriff (PDF)

Delayed Solid Tumor Presentations in Adolescent and Young Adults Patients in the Bronx

Journal of adolescent and young adult oncology, 2024-04, Vol.13 (2), p.361

2024

Volltextzugriff (PDF)

SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma

Cancer, 2016-03, Vol.122 (6), p.868-874

2016

Volltextzugriff (PDF)

Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial

Cancer Immunology, Immunotherapy, 2022-10, Vol.71 (10), p.2485-2495

2022

Volltextzugriff (PDF)

Size-based detection of sarcoma circulating tumor cells and cell clusters

Oncotarget, 2017-10, Vol.8 (45), p.78965-78977

2017

Volltextzugriff (PDF)

CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma

PloS one, 2012-12, Vol.7 (12), p.e52426

2012

Volltextzugriff (PDF)

1 – 25 von 827

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(711)
Mit Volltextzugriff
(729)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(478)
Life Sciences & Biomedicine
(360)
Humans
(327)
Male
(185)
Female
(149)
Biological And Medical Sciences
(102)
Oncology
(92)
Middle Aged
(91)
Adult
(84)
Aged
(84)
Medical Sciences
(76)
Animals
(75)
Science & Technology - Other Topics
(73)
Multidisciplinary Sciences
(72)
Child
(71)
Adolescent
(67)
Tumors
(63)
Infectious Diseases
(57)
Pediatrics
(53)
Physical Sciences
(52)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(58)
The American Journal Of Gastroenterology
(23)
Biology Of Blood And Marrow Transplantation
(22)
Cancer Research
(20)
Blood
(18)
Gastrointestinal Endoscopy
(15)
Gastroenterology
(14)
Pediatric Blood & Cancer
(14)
Journal Of Clinical Oncology
(13)
Open Forum Infectious Diseases
(13)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cells

Delayed presentations of pediatric solid tumors at a tertiary care hospital in the Bronx due to COVID‐19

IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

Treatment pathway of bone sarcoma in children, adolescents, and young adults

Breaking down the tumor immune infiltration within pediatric sarcomas

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition

SARS‐CoV‐2 as a mimicker of pulmonary metastasis in osteosarcoma

Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma

WT1 Protein Directly Regulates Expression of Vascular Endothelial Growth Factor and Is a Mediator of Tumor Response to Hypoxia

Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA

Cell-cycle dependent expression of a translocation-mediated fusion oncogene mediates checkpoint adaptation in rhabdomyosarcoma

Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor

Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma

Outcome for children with metastatic solid tumors over the last four decades

An evolutionary framework for treating pediatric sarcomas

Pembrolizumab as maintenance therapy for malignant rhabdoid tumor

Respiratory Failure Due to Idiopathic Pneumonia Syndrome in a Pediatric Patient After Recipient-derived Allogeneic Chimeric Antigen Receptor T-Cell Therapy

Consensus and controversies regarding the treatment of rhabdomyosarcoma

A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy

Delayed Solid Tumor Presentations in Adolescent and Young Adults Patients in the Bronx

SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma

Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial

Size-based detection of sarcoma circulating tumor cells and cell clusters

CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma

Suchergebnisse filtern